Cargando...
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals (NCT01508468). Patients with biopsy-proven PMN and nephrotic syndrome after 6 months of nonimmunosuppressive antiproteinuric...
Guardado en:
| Publicado en: | J Am Soc Nephrol |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Nephrology
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5198292/ https://ncbi.nlm.nih.gov/pubmed/27352623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016040449 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|